Currently, there are 217.25M common shares owned by the public and among those 203.18M shares have been available to trade.
The company’s stock has a 5-day price change of -11.01% and 50.95% over the past three months. EXK shares are trading 142.13% year to date (YTD), with the 12-month market performance up to 131.55% higher. It has a 12-month low price of $1.42 and touched a high of $5.67 over the same period. EXK has an average intraday trading volume of 5.44 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.71%, 17.07%, and 48.30% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Endeavour Silver Corp (NYSE: EXK) shares accounts for 37.15% of the company’s 217.25M shares outstanding.
It has a market capitalization of $1.58B and a beta (3y monthly) value of 1.71. The earnings-per-share (ttm) stands at -$0.06. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.15% over the week and 5.27% over the month.
Analysts forecast that Endeavour Silver Corp (EXK) will achieve an EPS of -0.01 for the current quarter, 0.01 for the next quarter and 0.34 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.04 while analysts give the company a high EPS estimate of -0.04. Comparatively, EPS for the current quarter was -0.01 a year ago. Earnings per share for the fiscal year are expected to decrease by -459.33%, and 1009.20% over the next financial year.
Looking at the support for the EXK, a number of firms have released research notes about the stock. BMO Capital Markets stated their Outperform rating for the stock in a research note on June 17, 2024, with the firm’s price target at $6. B. Riley FBR on their part issued Buy rating on July 21, 2020.
